Tag: T cell engager

MAGE-A4/MAGE-A8-Targeted Bispecific T Cell Engager Shows Promise in Refractory Solid Tumors

Novel bispecific T cell engager IMA401 targeting MAGE-A4/MAGE-A8 shows encouraging safety and preliminary efficacy in phase 1a trial. Early results…